Renal amyloidosis in intravenous drug users
نویسندگان
چکیده
منابع مشابه
Renal amyloidosis in intravenous drug users.
BACKGROUND Intravenous drug abuse is associated with a wide variety of acute and chronic medical complications. The increased longevity of drug users has seen the emergence of new diseases as a result of chronic bacterial and viral infection. We recently observed an increase in the number of cases of renal amyloidosis among intravenous drug users in central London. AIM To describe here the de...
متن کاملRenal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
BACKGROUND Chronic renal disease is a serious complication of long-term intravenous drug use (IVDU). Recent reports have postulated a changing pattern of underlying nephropathy over the last decades. METHODS Retrospective investigation including all patients with prior or present IVDU that underwent renal biopsy because of chronic kidney disease between 01.04.2002 and 31.03.2012 in the city o...
متن کاملhcv in intravenous drug users
background: hepatitis c (hcv) is increasing worldwide including iran. hcv is more prevalent among intravenous drug abusers (idu), especially if imprisoned, mostly due to needle sharing. we determined the rate of hcv seropositivity among idu prisoners and compared it with those of non prisoners. materials and methods: a cross-sectional survey was done on consenting idu inhabiting two prisons and...
متن کاملAcute infections in intravenous drug users.
pneumonia (CAP), including aspiration pneumonia, and a greater incidence of pulmonary tuberculosis compared with the general population. This relates to smoking, alcohol abuse, poor nutrition and homelessness. Organisms commonly causing CAP in this group include Streptococcus pneumoniae, S aureus, Haemophilus influenzae and Klebsiella pneumoniae.11,12 Septic pulmonary emboli can seed from injec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: QJM
سال: 2006
ISSN: 1460-2725,1460-2393
DOI: 10.1093/qjmed/hcl092